US Start-Up Phlow Receives Further Capital Injection To Fund Essential Medicines

Cash Will Be Used For Multiple Key Initiatives

 
• By Dean Rudge

Fresh from its $812m government contract to help prevent shortages of essential medicines and shield the US market from global competition, domestic start-up Phlow Corporation has received further financial backing.

Made_In_USA_Flag
Domestic manufacturing and production of essential medicines, considering heavy reliance on China and other countries for API supplies, remains a hot topic in the US • Source: Shutterstock

More from Manufacturing

More from Business